End-of-day quote
Shanghai S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
12.23
CNY
|
+2.34%
|
|
+7.19%
|
-23.66%
|
Fiscal Period: December |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,732
|
5,209
|
6,084
|
6,178
|
4,716
|
-
|
-
|
Enterprise Value (EV)
1 |
3,732
|
5,209
|
6,084
|
6,178
|
4,716
|
4,716
|
4,716
|
P/E ratio
|
-
|
92.2
x
|
50.1
x
|
58.7
x
|
29.8
x
|
20.8
x
|
17.6
x
|
Yield
|
0.29%
|
0.34%
|
-
|
0.53%
|
5.56%
|
13.2%
|
-
|
Capitalization / Revenue
|
7.61
x
|
6.58
x
|
-
|
6
x
|
3.79
x
|
2.78
x
|
2.5
x
|
EV / Revenue
|
7.61
x
|
6.58
x
|
-
|
6
x
|
3.79
x
|
2.78
x
|
2.5
x
|
EV / EBITDA
|
-
|
-
|
-
|
31.4
x
|
17.7
x
|
13.4
x
|
11.2
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
4.72
x
|
4.51
x
|
-
|
3.78
x
|
2.74
x
|
2.46
x
|
-
|
Nbr of stocks (in thousands)
|
311,886
|
331,193
|
385,638
|
385,637
|
385,637
|
-
|
-
|
Reference price
2 |
11.97
|
15.73
|
15.78
|
16.02
|
12.23
|
12.23
|
12.23
|
Announcement Date
|
3/11/20
|
3/14/22
|
3/12/23
|
3/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
490.4
|
-
|
792.1
|
-
|
1,030
|
1,246
|
1,696
|
1,888
|
EBITDA
1 |
-
|
-
|
-
|
-
|
196.5
|
267
|
351
|
420
|
EBIT
1 |
35.64
|
-
|
64.44
|
-
|
83.6
|
113
|
226.5
|
204
|
Operating Margin
|
7.27%
|
-
|
8.13%
|
-
|
8.12%
|
9.07%
|
13.35%
|
10.8%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
61.58
|
-
|
82.16
|
111
|
228.5
|
202
|
Net income
1 |
-
|
58.19
|
56.51
|
105.8
|
105.3
|
159.2
|
225.7
|
267
|
Net margin
|
-
|
-
|
7.13%
|
-
|
10.22%
|
12.78%
|
13.31%
|
14.14%
|
EPS
2 |
-
|
-
|
0.1706
|
0.3151
|
0.2729
|
0.4100
|
0.5867
|
0.6950
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0350
|
-
|
0.0532
|
-
|
0.0850
|
0.6800
|
1.610
|
-
|
Announcement Date
|
3/11/20
|
3/29/21
|
3/14/22
|
3/12/23
|
3/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
4.43%
|
6.97%
|
4.99%
|
9.68%
|
6.27%
|
8.69%
|
11.6%
|
12.3%
|
ROA (Net income/ Total Assets)
|
2.93%
|
-
|
2.67%
|
-
|
-
|
4.2%
|
7%
|
7.6%
|
Assets
1 |
-
|
-
|
2,118
|
-
|
-
|
3,791
|
3,225
|
3,513
|
Book Value Per Share
2 |
2.530
|
-
|
3.490
|
-
|
4.240
|
4.470
|
4.980
|
-
|
Cash Flow per Share
2 |
0.1400
|
-
|
-0.1500
|
-
|
0.3800
|
0.7200
|
0.9100
|
-
|
Capex
1 |
199
|
-
|
230
|
-
|
98.6
|
100
|
225
|
200
|
Capex / Sales
|
40.57%
|
-
|
28.97%
|
-
|
9.57%
|
8.03%
|
13.26%
|
10.59%
|
Announcement Date
|
3/11/20
|
3/29/21
|
3/14/22
|
3/12/23
|
3/15/24
|
-
|
-
|
-
|
Last Close Price
12.23
CNY Average target price
18
CNY Spread / Average Target +47.18% Consensus |
1st Jan change
|
Capi.
|
---|
| -23.66% | 651M | | +11.47% | 63.22B | | -2.59% | 46.34B | | +13.98% | 39.97B | | +17.83% | 25.46B | | +7.49% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +1.42% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|